Connection
Steven Abman to Endothelin Receptor Antagonists
This is a "connection" page, showing publications Steven Abman has written about Endothelin Receptor Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.988 |
|
|
|
-
Abman SH. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. Annu Rev Med. 2009; 60:13-23.
Score: 0.321
-
Abman SH. Pulmonary hypertension in older children: new approaches and therapies. Paediatr Respir Rev. 2006; 7 Suppl 1:S177-9.
Score: 0.268
-
Ivy DD, Parker TA, Kinsella JP, Abman SH. Endothelin A receptor blockade decreases pulmonary vascular resistance in premature lambs with hyaline membrane disease. Pediatr Res. 1998 Aug; 44(2):175-80.
Score: 0.156
-
Ivy DD, Parker TA, Ziegler JW, Galan HL, Kinsella JP, Tuder RM, Abman SH. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest. 1997 Mar 15; 99(6):1179-86.
Score: 0.141
-
Ivy DD, Parker TA, Abman SH. Prolonged endothelin B receptor blockade causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2000 Oct; 279(4):L758-65.
Score: 0.045
-
Ivy DD, Kinsella JP, Abman SH. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest. 1994 May; 93(5):2141-8.
Score: 0.029
-
Wolf D, Tseng N, Seedorf G, Roe G, Abman SH, Gien J. Endothelin-1 decreases endothelial PPAR? signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2014 Feb 15; 306(4):L361-71.
Score: 0.028